B. M. van der Sluijs

Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients

S. Anvar, P. ’. ‘t Hoen, G. Dickson, 2011, Skeletal Muscle.

A decline in PABPN1 induces progressive muscle weakness in Oculopharyngeal muscle dystrophy and in muscle aging

J. Goeman, S. Anvar, P. ’. ‘t Hoen, 2013, Aging.

Oculopharyngeal muscular dystrophy (OPMD) due to a small duplication in the PABPN1 gene

L. Hoefsloot, B. V. van Engelen, B. M. van der Sluijs, 2003, Human mutation.

Ptosis aggravates dysphagia in oculopharyngeal muscular dystrophy

J. Cruysberg, B. D. de Swart, B. V. van Engelen, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

Longitudinal Assessment of Strength, Functional Capacity, Oropharyngeal Function, and Quality of Life in Oculopharyngeal Muscular Dystrophy

J. Glennon, C. Horlings, B. D. de Swart, 2021, Neurology.

Intranuclear Aggregates Precede Clinical Onset in Oculopharyngeal Muscular Dystrophy.

L. V. D. Heuvel, B. V. van Engelen, L. P. Van den Heuvel, 2016, Journal of neuromuscular diseases.

Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy

G. Dickson, B. V. van Engelen, S. M. van der Maarel, 2013, BMC Neurology.

Autosomal recessive oculopharyngodistal myopathy: a distinct phenotypical, histological, and genetic entity

B. V. van Engelen, H. Scheffer, H. T. ter Laak, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

Behavioural Impairment and Frontotemporal Dementia in Oculopharyngeal Muscular Dystrophy

R. Kessels, C. Horlings, B. V. van Engelen, 2021, Journal of neuromuscular diseases.